Z-2540-2016 Class II Terminated

Recalled by TYRX Inc. — Monmouth Junction, NJ

FDA device recall Z-2540-2016 was initiated by TYRX Inc. on June 29, 2016 and is designated Class II. Reason for recall: TRYX products are being recalled since the processes of spaying, welding, drying oven and polymer were not adequately validated. The recall status is terminated (terminated December 12, 2017). Affected quantity: 2993 units.

Recall Details

Product Type
Devices
Report Date
August 24, 2016
Initiation Date
June 29, 2016
Termination Date
December 12, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2993 units

Product Description

TRYX Absorbable Antibacterial Envelope Product Usage: Indicated for stabilization of implanted pacemakers (IPG) and/or implantable cardioverter defibrillators (ICD)

Reason for Recall

TRYX products are being recalled since the processes of spaying, welding, drying oven and polymer were not adequately validated.

Distribution Pattern

US Nationwide Distribution

Code Information

model number CMRM6122 lot number 16E03727 16E05728 model number CMRM6133 lot number 16E02726 16E06729